EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 14,130
+310 (2.24%)
Sep 19, 2025, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 517.50 billion as of September 19, 2025. Its market cap has increased by 25.86% in one year.
Market Cap
517.50B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
20.81
Stock Price
14,130.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 517.50B, an increase of 321.22%. That is a compound annual growth rate of 18.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 517.50B | 16.58% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1,271.41B | 93.99% |
| Dec 30, 2020 | 655.40B | 209.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.24T |
| Celltrion | 37.12T |
| ALTEOGEN | 25.30T |
| Yuhan | 8,752.85B |
| SK Biopharmaceuticals | 8,450.00B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,316.91B |
| ABL Bio | 5,473.88B |